Algo version: 0.98b
Grifols, S.A. is listed at the EURONEXT Exchange
Grifols, S.A. [GRF.MC]
EURONEXT Sector: Healthcare Industry:Drug Manufacturers—General

Is Grifols, S.A. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Grifols, S.A. pays dividends. Last time was Monday 7th of June 2021 where the investors holding the stock on Thursday 3rd of June 2021 were paid €0.36435 per share. Over the last 20 times between 2007 and 2021, Grifols, S.A. has paid €4.44248 with an average of €0.22 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Grifols, S.A. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €27.40, you would have made a loss of €-18.09 per share or -66.02%

Yes, the average daily trading liquidity for Grifols, S.A. is €2.42 million. You should therefore be able to get in and out of your positions relatively fast.

Grifols, S.A. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.03, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 2.51%, which is challenging.

We have calculated the inflation risk for Grifols, S.A. to be medium [0.65 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.